Stockscreener 앱 받기
5.95
3.66%
0.21
시간 외 거래:
5.90
-0.05
-0.84%
전일 마감가:
$5.74
열려 있는:
$5.76
하루 거래량:
5.19M
Relative Volume:
1.11
시가총액:
$1.14B
수익:
$71.80M
순이익/손실:
$-183.59M
주가수익비율:
-5.6436
EPS:
-1.0543
순현금흐름:
$-186.52M
1주 성능:
+5.12%
1개월 성능:
-12.11%
6개월 성능:
-63.59%
1년 성능:
-9.71%
1일 변동 폭
$5.76
$6.065
1주일 범위
$5.40
$6.065
52주 변동 폭
$5.02
$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
명칭
Wave Life Sciences Ltd
전화
617-949-2900
주소
7 STRAITS VIEW, SINGAPORE
Compare WVE vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
5.95 | 1.15B | 71.80M | -183.59M | -186.52M | -1.0543 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-05 | 개시 | BofA Securities | Buy |
| 2025-12-12 | 재확인 | Wedbush | Outperform |
| 2025-12-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-04 | 개시 | Canaccord Genuity | Buy |
| 2025-07-28 | 개시 | Oppenheimer | Outperform |
| 2025-07-16 | 개시 | Citigroup | Buy |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Wedbush | Outperform |
| 2025-02-25 | 개시 | Jefferies | Buy |
| 2024-10-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | 재개 | JP Morgan | Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-09-09 | 개시 | JP Morgan | Overweight |
| 2024-05-15 | 개시 | Wells Fargo | Overweight |
| 2023-12-19 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 개시 | Raymond James | Outperform |
| 2023-05-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-15 | 재개 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 개시 | Guggenheim | Buy |
| 2019-07-15 | 개시 | Cowen | Market Perform |
| 2019-04-17 | 재확인 | H.C. Wainwright | Buy |
| 2018-08-07 | 개시 | Stifel | Buy |
| 2018-07-23 | 개시 | H.C. Wainwright | Buy |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2017-02-15 | 개시 | H.C. Wainwright | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-12-07 | 개시 | JMP Securities | Mkt Outperform |
| 2015-12-07 | 개시 | Jefferies | Buy |
| 2015-12-07 | 개시 | Leerink Partners | Outperform |
| 2015-12-07 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Wave Life Sciences Ltd 주식(WVE)의 최신 뉴스
Wave Life Sciences Ltd. (WVE) stock price, news, quote and history - Yahoo Finance UK
Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now? - Insider Monkey
What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits
ARWR Stock Slid Lower Today — What Does Wave Life Sciences Have To Do With It? - Stocktwits
WVE News | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill
Failed Obesity Trial And Investor Exit Might Change The Case For Investing In Wave Life Sciences (WVE) - Sahm
Inside Wells Fargo’s Take on Wave Life Sciences Ltd (WVE) Stock - Insider Monkey
H.C. Wainwright Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential - Insider Monkey
WVE Stock Price, Quote & Chart - ChartMill
(WVE) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Transcript : Wave Life Sciences Ltd. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08 - marketscreener.com
WVE: WVE-007 advances to phase II-A for obesity, with RNA editing programs nearing key milestones - TradingView
Wave Life Sciences (WVE) Valuation After Obesity Drug Setback And Institutional Investor Exit - simplywall.st
Wave Life Sciences Faces Setback As WVE-007 Fails And Investor Exits - simplywall.st
WAVE LIFE SCIENCES LTD (WVE) Stock Chart - ChartMill
Wave Life Sciences Hits Day Low at $5.65 Amid Price Pressure - MarketsMojo
Wave Life Sciences to Present at Upcoming Investor Conferences - The Manila Times
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter - AOL.com
Is RNA Editor WVE-006’s MZ-Like AAT Restoration Altering The Investment Case For Wave Life Sciences (WVE)? - simplywall.st
Wave Life Science prices upsized $350M stock ofeering - MSN
Wells Fargo Maintains Wave Life Sciences (WVE) Overweight Recommendation - MSN
(WVE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
EDGAR Filing Documents for 0001193125-25-044876 - SEC.gov
Wedbush Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Investigation launched into Wave Life Sciences over possible securities law violations after stock drop - Pluang
Wave Life Sciences Ltd. Shareholders Are Encouraged to - GlobeNewswire
Wave Life Sciences(WVE) Stock Options Chain | Quotes & News - Moomoo
Should WVE-006’s RNA-Editing AAT Data Shift the Risk-Reward Calculus for Wave Life Sciences (WVE) Investors? - Yahoo Finance
Wave Life Sciences (WVE) Valuation Check After Sharp Share Price Weakness - simplywall.st
WAVE Life Sciences Analyst Ratings and Price Targets | NASDAQ:WVE - Benzinga
Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Wave Life Sciences (WVE) Is Down 11.4% After Positive WVE-006 AATD Data and Accelerated Path Update - simplywall.st
Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data - Seeking Alpha
WVE Maintained by Wells Fargo -- Price Target Raised to $14.00 - GuruFocus
Wave Life Sciences Is Maintained at Overweight by Wells Fargo - Moomoo
CCORF Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $43 - Moomoo
WVE: Advancing siRNA and RNA editing therapies with strong clinical data and regulatory momentum - TradingView
Wells Fargo raises Wave Life Sciences price target on AATD data - Investing.com Australia
Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $14 - Moomoo
Wave Life Sciences Signals Momentum in Earnings Call - TipRanks
Wave Life Sciences crashes deep into oversold territory as obesity drug data disappoints. Should you buy the dip? - MSN
WVE Maintained by HC Wainwright & Co. -- Price Target Lowered to $13 - GuruFocus
Wave Life Sciences' New Data From AATD Study Met Expectations, Wedbush Says - Moomoo
Cantor Fitzgerald reiterates Overweight on Wave Life Sciences stock By Investing.com - Investing.com South Africa
Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 - PR Newswire
Wave Life Sciences Ltd (WVE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Wave Life Sciences Ltd 주식 (WVE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Mar 27 '26 |
Buy |
6.43 |
2,495,623 |
16,046,856 |
26,004,414 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Mar 30 '26 |
Buy |
6.50 |
971,091 |
6,312,092 |
26,975,505 |
| Francis Chris | See Remarks |
Feb 26 '26 |
Option Exercise |
4.28 |
33,194 |
141,920 |
79,767 |
| Francis Chris | See Remarks |
Feb 26 '26 |
Sale |
15.05 |
33,194 |
499,593 |
61,867 |
| Moran Kyle | Chief Financial Officer |
Feb 09 '26 |
Sale |
13.45 |
3,588 |
48,259 |
134,385 |
| BOLNO PAUL | President and CEO |
Feb 09 '26 |
Sale |
13.45 |
10,480 |
140,956 |
275,520 |
| Francis Chris | See Remarks |
Feb 09 '26 |
Sale |
13.45 |
1,883 |
25,326 |
61,867 |
| Vargeese Chandra | See Remarks |
Feb 09 '26 |
Sale |
13.45 |
3,228 |
43,417 |
408,246 |
2.60%
0.94%
자본화:
|
볼륨(24시간):